Project Grant R21NS144983
Award Date 8/1/26
Completion Date 7/31/28
Dollars Obligated $429K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Portland, OR 97239, USA
Similar Awards
- The National Institute of Neurological Disorders and Stroke, part of the Department of Health and Human Services, awarded Oregon Health & Science University $507,491 under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) on August 12, 2026. The award funds investigation into the mechanistic basis of astrocyte-neuron signaling during neuronal remodeling in the developing brain. The research uses Drosophila models to understand how...
- The National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health, awarded Oregon Health & Science University $858,000 on September 24, 2025, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The award funds in vivo investigations of astrocyte-oligodendrocyte interactions using molecular, genetic, cellular, and proteomic tools to define astrocyte-oligodendrocyte myelin interactions at the...
- The National Institute of Neurological Disorders and Stroke awarded Oregon Health & Science University $619,833 on August 15, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to decode PARP7 marylation-ubiquitylation crosstalk in neuronal health and disease. The research will identify neuronal PARP7 substrates and marylation sites using chemical-genetic proteomics; establish the enzymatic machinery (writers, extenders, and...
- The National Institute of Neurological Disorders and Stroke awarded Oregon Health & Science University $429,000 on June 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to develop and optimize a chemical-genetic method for rapid, cell type-specific labeling of newly synthesized proteins in nervous system tissue. The project, titled "Rapid and Cell Type Specific Nascent Proteome Labeling in the Nervous System,"...
- The National Institute of Neurological Disorders and Stroke awarded Oregon Health & Science University $247,702 on December 1, 2025, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to investigate neuronal and glial mechanisms regulating PAIR1 local pruning. The research examines how neurons and glia communicate during synaptic pruning—the process by which developing nervous systems eliminate excess neuronal connections. Using...
- The National Institute of Neurological Disorders and Stroke awarded Oregon Health & Science University $536,121 on May 15, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) for Project Grant R01NS144584. The award funds research into the metabolic basis for oligodendrocyte-vascular interactions in white matter development and injury, with focus on neonatal white matter injury resulting from hypoxia-ischemia in preterm and...
- Federal Project Grant Award Summary Oregon Health & Science University (OHSU) received a $420,744 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, awarded June 1, 2025, with a completion date of May 31, 2027. This research project focuses on profiling adenosine-to-inosine (A-to-I) editing in single neurons, a post-transcriptional RNA modification...
- The National Institute of Neurological Disorders and Stroke awarded Oregon Health & Science University $344,817 on May 23, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to support research on metabolic coupling of oligodendroglia and endothelial cells through cell-specific lactate dehydrogenase A. The research investigates how oligodendrocyte progenitors meet metabolic demands during remyelination after white matter injury,...
- The National Institute of Neurological Disorders and Stroke, part of the Department of Health and Human Services National Institutes of Health, awarded $555,000 to Augusta University Research Institute, Inc. on May 7, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The award funds development of a novel optogenetic assay to study intracellular transport defects in neurodevelopmental diseases. The research addresses how motor...
- The National Institute of Neurological Disorders and Stroke awarded the University of Washington $502,070 on April 21, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853, Assistance Listing 93.853) to investigate mechanisms of axon length-dependent degeneration in neurodegenerative disorders. The research uses Drosophila melanogaster as a model system to identify genetic pathways regulating neuronal production of UPD3, a...